CRP and infection: Both the IDSA and IWGDF guidelines [17–19] suggest combining various clinical findings (e.g., resolution of soft tissue inflammation and wound healing), laboratory markers (especially normalization of elevated CRP and ESR), and imaging tests (e.g., signs of radiological healing and absence of evidence of infection on advanced imaging) to determine the efficacy of treatment in DFO [93, 94].